Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06468410
Other study ID # 2023-34
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2023
Est. completion date December 1, 2023

Study information

Verified date June 2024
Source Princess Nourah Bint Abdulrahman University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to to investigate the acute and chronic effects of a four-week hatha yoga (HY) exercise program with different durations (60 min and 30 min) on pulmonary function in sedentary young individuals.. The main questions it aims to answer are: • Does a four-week hatha yoga (HY) more effective than 30 min of a four-week hatha yoga (HY) and the control group in improving the pulmonary function? Researchers will compare a four-week OF 60 min duration hatha yoga (HY) , 30 min duration of HY and control to see the differences in the pulmonary function among high school sedentary students Participants will: Participants will be randomly assigned to one of three groups: 1. 60-minute Hatha Yoga group (60mHY, n=21) 2. 30-minute Hatha Yoga group (30mHY, n=21) 3. Control group (CG, n=21)


Description:

Objective: To investigate the acute and chronic effects of a four-week hatha yoga (HY) exercise program with different durations (60 minutes and 30 minutes) on pulmonary function in sedentary young individuals aged 15-16 years. Study Design: Randomized Controlled Trial (RCT) Participants: • Sample Size: 52 sedentary individuals Inclusion Criteria: - High school adolescence - Showed Sedentary lifestyle (defined as not participating in regular physical activity for at least 6 months. Exclusion Criteria: - Any known history of pulmonary, cardiovascular, or musculoskeletal conditions that would contraindicate exercise, - participation in any other exercise program during the study period - obesity (BMI > 25.00) - Participants who are in medication that stimulate the heart of medication such as antibiotic use were excluded from the study Randomization: Participants will be randomly assigned to one of three groups: 4. 60-minute Hatha Yoga group (60mHY, n=21) 5. 30-minute Hatha Yoga group (30mHY, n=21) 6. Control group (CG, n=21) Intervention: - 60mHY Group: Participants will undergo a 60-minute hatha yoga session twice a week for four weeks. - 30mHY Group: Participants will undergo a 30-minute hatha yoga session twice a week for four weeks. - Control Group: Participants will receive information about physical activity guidelines but will not engage in any structured yoga exercise during the study period. Outcome Measures: • Primary Outcome: Pulmonary function measured by spirometry.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date December 1, 2023
Est. primary completion date April 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 15 Years to 18 Years
Eligibility Inclusion Criteria: - High school adolescence - Sedentary lifestyle (defined as not participating in regular physical activity for at least 6 months. Exclusion Criteria: - Any known history of pulmonary, cardiovascular, or musculoskeletal conditions that would contraindicate exercise, - participation in any other exercise program during the study period - obesity (BMI > 25) - Participants who are on medication that stimulates the heart of medication such as antibiotic use were excluded from the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
long duration Hatha Yoga
60 min of Hatha yoga for 4 weeks. Week One:Participants begin with foundational breathing and yoga practicesOn the second day, Square Breathwork is introduced to foster calm and concentration. After a warm-up, the yoga flow focuses on heart openers to increase chest and shoulder flexibility, ending with a soothing cool-down. Week Two:Advanced breathing techniques and targeted yoga flows are introduced. The second session includes Nadi Shodhana to balance the nervous system. Week Three:The focus remains on heart openers with varied breathing exercises. The second day revisits Full Yogic Breath, followed by a warm-up and another heart opener sequence, concluding with a cool-down. Week Four:The final week integrates additional breathing techniques. The last session features Kapalabhati and Suddhi Pranayama to purify and energize the body. After a warm-up, participants engage in a well-rounded yoga flow combining various poses to enhance overall fitness, concluding with a final cool-down.
short duration Hatha Yoga
30 min of Hatha yoga for 4 weeks .
Control group
participants will receive information about physical activity guidelines but will not engage in any structured yoga exercise during the study period.

Locations

Country Name City State
Turkey Bandirma Onyedi Eylul University Balikesir

Sponsors (3)

Lead Sponsor Collaborator
Monira Aldhahi Bandirma Onyedi Eylül University, Çankiri Karatekin University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Forced Vital Capacity (FVC) the maximum amount of air a person can exhale after taking a deep breath measured using spirometry at baseline and end of 4 week
Primary Forced Expiratory Volume in 1 second (FEV1) spirometry will be used to measure Forced Expiratory Volume in 1 second (FEV1). It is the volume of air (in liters) exhaled in the first second during forced exhalation after maximal inspiration. at baseline and end of 4 week
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1